ThursdayMar 23, 2017 9:38 am

CBDNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Audio Interview with CBDWire

Multifaceted financial news and publishing company CBDWire this morning announced the online availability of a new audio interview with India Globalization Capital, Inc. (NYSE MKT: IGC) CEO Ram Mukunda. In the interview, Mukunda discusses IGC’s operations and targeted market, as well as leading formulations currently in the company’s development pipeline. “This is a very exciting time for us, an exciting opportunity,” Mukunda noted in the interview. “We believe that we have first-mover advantage in combination therapy, as very few companies are actually working on cannabis-based pharmaceuticals and within that space we believe that we are the only ones working on…

Continue Reading

WednesdayMar 22, 2017 2:38 pm

CBDNewsBreaks – InMed Pharmaceuticals (IMLFF) Featured in Forbes Article Discussing Unique Cannabinoid Manufacturing System and Database

InMed Pharmaceuticals (OTCQB: IMLFF) was recently featured in a Forbes article highlighting the company's cannabinoid manufacturing system and database, which is used to map different compounds of cannabinoids to the various diseases they are able to treat. According to the article, InMed’s database appeals to other biotech companies who are now willing to purchase the information. Using its database, InMed has been able to identify two new cannabinoid therapies. Additionally, the company has created a method of biosynthesis for cannabinoids that is comparable to the system used to create synthetic insulin for diabetic patients. The company begins with the cannabinoid…

Continue Reading

TuesdayMar 21, 2017 9:58 am

CBDNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Files Provisional Patent for Treatment of Eating Disorders Using Cannabis Extracts

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. Should this filing result in the issuance of a patent, IGC intends to develop its IGC-506 candidate for both human and veterinary use. “The development of cannabis-based combination therapies represents a large, unique opportunity, and we believe we are the first mover in this emerging specialty-pharmaceutical sector,” Ram Mukunda, chief executive officer…

Continue Reading

ThursdayMar 16, 2017 12:35 pm

CBDNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

Continue Reading

ThursdayMar 16, 2017 10:40 am

CBDNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of CBDWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of CBDWire (“CBDW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, CBDW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

Continue Reading

TuesdayMar 14, 2017 10:12 am

CBDNewsBreaks – SinglePoint, Inc. (SING) Expands Presence in Cannabis Industry through Acquisition of Stake in Convectium

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has closed its first round of funding to acquire a stake in Jacksam Corp., dba Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis industry. Originally announced at the end of January, the Convectium acquisition is expected to include an overall investment of stock and cash consideration totaling $800,000, which Convectium will use to help fund its growth as well as marketing of its revolutionary 710Shark and 710Seal system. Leaning on the marketability of the first-of-its-kind system, as well as its line of…

Continue Reading

FridayMar 03, 2017 11:21 am

CBDNewsBreaks – NEMUS Bioscience, Inc. (NMUS), Catalent to Advance Development of NB1222 Human Dosage Formulation

NEMUS Bioscience (OTCQB: NMUS) this morning said it is moving forward with Catalent Pharma Solutions to advance development of a human-dosage suppository formulation of NB1222. NB1222 is the proprietary prodrug of tetrahydrocannabinol (THC) being developed for the treatment and management of chemotherapy-induced nausea and vomiting (CINV). NB1222, also known as the prodrug THC-valine-hemisuccinate, is synthetically manufactured and is not plant-derived. "The global CINV market is a multi-billion dollar opportunity with projected growth as populations live longer, increasing the likelihood of developing a malignancy over time," Nemus CEO and chief medical officer Brian Murphy, M.D. stated in the news release. To…

Continue Reading

ThursdayFeb 16, 2017 9:37 am

CBDNewsBreaks – Player’s Network, Inc. (PNTV) Uplists to the OTCQB Venture Market

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) this morning announced that its common shares are now trading on the OTCQB Venture Market, effective February 16, 2017. In order to be eligible for listing on the OTCQB Venture Market, which is designed for entrepreneurial and development-stage companies, Player’s Network was required to be current in its financial reporting and undergo an annual company verification and management certification process. “We are proud to announce this corporate milestone as we execute our plan to add tenure to our 23-year track record as a fully reporting company,” Mark Bradley, CEO of Player’s Network,…

Continue Reading

MondayFeb 13, 2017 9:20 am

CBDNewsBreaks – ChineseInvestors.com (CIIX) Issues Update on Recent Financial and Business Achievements

ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning issued a news release highlighting some of its financial and business achievements for January 2017, as well as its plans to build on these milestones moving forward. After reporting significantly higher revenues for the three- and six-month periods ended November 30, 2016, the company has now achieved revenue growth for three consecutive quarters, and ChineseInvestors.com will look to continue this trend through its entry into the hemp-based cannabidiol (CBD) health products market. In addition to completing a $5 million private placement, the company kicked off 2017 with the launch of its new www.ChineseCBDoil.com site,…

Continue Reading

TuesdayFeb 07, 2017 9:50 am

CBDNewsBreaks – SinglePoint, Inc. (SING) Announces Position as a Debt-Free Company

Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning announced that it is now officially debt-free. The milestone comes as a result of the company’s ongoing fundraising initiatives, which have already resulted in the addition of more than $300,000 of working capital to its balance sheet. SinglePoint has also entered into a Letter of Intent stemming from these efforts that’s expected to result in the securement of $1 million of additional funding. Per this morning’s update, SinglePoint intends to use the capital from these fundraising efforts to support its proposed uplisting to the OTCQB Venture Market later…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722